VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CLColgate-Palmolive Company
$90.10$72.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLCash Flow

Colgate-Palmolive Company (CL) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash conversion remains strong with OCF/NI averaging 1.3x over ten quarters and FCF margin of 16.2% in 2026Q2, but shareholder returns (dividends and buybacks) consumed 87% of FCF, leaving limited flexibility.

Income StatementBalance SheetCash FlowRatios

CL Cash Flow Statement

Annual statement

CL Cash Flow Statement

Colgate-Palmolive Company (CL) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations4.46B4.2B4.11B3.75B2.56B3.33B3.72B3.13B3.06B3.05B3.14B2.95B3.3B3.2B3.2B2.9B3.21B3.28B2.3B2.2B1.82B1.78B1.75B1.77B1.61B1.5B1.54B1.29B1.18B1.1B917.4M
Operating CF Margin %-20.6%20.43%19.25%14.23%19.09%22.58%19.96%19.66%19.76%20.67%18.39%19.09%18.39%18.71%17.31%20.63%21.38%15.02%15.98%14.88%15.66%16.57%17.85%17.34%15.95%16.42%14.18%13.14%12.12%10.49%
Operating CF Growth %59.61%2.22%9.67%46.52%-23.13%-10.59%18.7%2.52%0.07%-2.77%6.51%-10.58%2.93%0.25%10.36%-9.81%-2.01%42.35%4.46%20.98%2.08%1.72%-0.76%9.71%7.13%-2.1%18.84%9.66%7.38%19.66%13.23%
Net Income2.04B2.13B3.05B2.46B1.97B2.34B2.86B2.53B2.56B2.17B2.59B1.55B2.34B2.41B2.63B2.55B2.31B2.4B1.96B1.74B1.35B1.35B1.33B1.42B1.29B1.15B1.06B937.3M848.6M740.4M635M
Depreciation & Amortization642M630M605M567M545M556M539M519M511M475M443M449M442M439M425M421M376M351M348M333.9M328.7M329.3M327.8M315.5M296.5M336.2M337.8M340.2M330.3M319.9M316.3M
Stock-Based Compensation110M0135M122M125M135M107M100M109M127M123M125M131M128M120M122M121M117M100M000000000000
Deferred Taxes-107M-109M-77M-98M-78M-132M-120M17M107M383M56M-51M18M71M63M88M29M-23M-6M-147.4M030.8M57.7M-48.8M5.3M146.4M197.1M060.7M18.5M13.2M
Other Non-Cash Items1.29B1.26B51M244M723M625M-48M-95M-74M10M-159M1B455M253M-66M-282M272M-23M-50M83M215.8M-26M-16.8M-137.5M-115.2M-106.5M-125.6M86.7M-34.8M-48.5M-105.6M
Working Capital Changes423M284M344M455M-726M-197M381M65M-155M-115M92M-122M-87M-97M23M-7M100M458M-47M196.8M-76.4M98.9M58.5M217.2M136.3M-18.8M63.1M-71.5M-26M67.5M58.5M
Change in Receivables-138M-16M-56M-37M-227M-84M138M19M-79M-15M-17M-75M-109M-37M19M-130M40M57M-70M-66.5M-116M-24.1M-5.6M-14.4M-18M19.4M-91.9M-81.3M-15.2M-61.6M-15.4M
Change in Inventory-4M109M-100M194M-333M-72M-251M-77M-58M-8M-4M-13M-60M-97M-21M-130M-10M44M-135M-111.5M-118.5M-46.8M-76.1M-3.1M-2.4M-18.7M59M-82.8M-19.5M-50.9M-1.2M
Change in Payables623M251M516M0000000000000000000000000000
Cash from Investing-501M-817M-534M-742M-1.6B-592M-878M-2.1B-1.17B-471M-499M-685M-859M-890M-865M-1.21B-658M-841M-613M-528.3M-620.4M-220.7M-1.09B-117.6M-357.2M-323.5M-208.6M-331.5M-351.9M-337.4M-504M
Capital Expenditures-598M-564M-561M-705M-696M-567M-410M-335M-436M-553M-593M-691M-757M-670M-565M-537M-550M-575M-684M-583.1M-476.4M-389.2M-348.1M-302.1M-343.7M-340.2M-366.6M-416.9M-412.2M-478.5M-459M
CapEx % of Revenue2.84%2.77%2.79%3.62%3.87%3.25%2.49%2.13%2.8%3.58%3.9%4.31%4.38%3.85%3.31%3.21%3.53%3.75%4.46%4.23%3.89%3.42%3.29%3.05%3.7%3.61%3.92%4.57%4.59%5.28%5.25%
Acquisitions-293M-293M00-809M0-452M-1.71B-728M0-5M208M-87M-3M-29M-966M000-26.5M-200M-38.5M-800.7M00-10.2M-64.9M0000
Investments-------------------------------
Other Investing276M-14M37M-33M52M-25M3M07M38M57M-59M42M21M127M223M33M23M61M92.3M57.2M217M38.8M142.6M-15M17.6M85.5M62.7M41.6M72.6M-46.2M
Cash from Financing-3.8B-3.26B-3.39B-2.79B-952M-2.77B-2.82B-870M-2.68B-2.45B-2.23B-2.28B-2.17B-2.14B-2.3B-1.24B-2.62B-2.27B-1.53B-1.75B-1.06B-1.52B-611.1M-1.56B-1.26B-1.21B-1.32B-940.1M-830M-813M-371.6M
Debt Issued (Net)-817M-456M-408M-314M1.65B-175M-564M1.43B-179M-29M164M421M435M422M441M1.41B296M-526M195M-224.7M139.1M-168.1M492.6M-574.8M201M292M186M64.5M85.4M-320.3M-87.2M
Equity Issued (Net)-1.12B-1.11B-1.74B-1.13B-1.31B-1.32B-602M-1.2B-1.24B-1.4B-1.33B-1.55B-1.53B-1.52B-1.94B-1.81B-2.02B-1.06B-1.07B-780.1M-520.3M-749.1M-567.5M-475.6M-1.08B-1.23B-1.04B-624.4M-542.5M-159.3M11.8M
Dividends Paid-1.82B-1.82B-1.79B-1.75B-1.69B-1.68B-1.5B-1.61B-1.59B-1.53B-1.51B-1.49B-1.45B-1.38B-1.28B-1.2B-1.14B-981M-889M-749.6M-677.8M-607.2M-536.2M-506.8M-413.4M-396.7M-382.4M-366M-345.6M-333.4M-296.2M
Share Repurchases-1.29B-1.21B-1.74B-1.13B-1.31B-1.32B-1.48B-1.2B-1.24B-1.4B-1.33B-1.55B-1.53B-1.52B-1.94B-1.81B-2.02B-1.06B-1.07B-1.27B-884.7M-796.2M-637.9M-554.9M-1.08B-1.23B-1.04B-624.4M-542.5M-175.1M-27.4M
Other Financing-47M132M547M398M400M400M-152M513M329M507M446M347M371M339M478M353M242M300M237M0000035.3M124.2M-79M-14.2M-27.3M00
Net Change in Cash155M192M130M191M-57M-56M5M157M-809M220M345M-119M127M78M6M388M-110M45M126M-60.8M148.8M21.1M54.3M97.4M-4.8M-33.9M7M17.9M-1.4M-65.1M-208.8M
Free Cash Flow3.86B3.63B3.55B3.04B1.86B2.76B3.31B2.8B2.62B2.5B2.55B2.26B2.54B2.53B2.63B2.36B2.66B2.7B1.62B1.62B1.35B1.4B1.41B1.47B1.27B1.16B1.17B875.8M766.6M619.3M458.4M
FCF Margin %18.33%17.83%17.64%15.62%10.35%15.83%20.09%17.83%16.86%16.18%16.77%14.08%14.71%14.55%15.4%14.1%17.1%17.63%10.55%11.75%10.99%12.24%13.29%14.8%13.64%12.34%12.5%9.61%8.54%6.84%5.24%
FCF Growth %14.48%2.48%16.64%63.44%-32.56%-16.65%18.26%6.79%4.76%-1.84%12.84%-11.14%0.28%-3.69%11.53%-11.35%-1.52%67%-0.16%20.48%-3.59%-0.78%-4.05%15.63%8.92%-0.5%33.55%14.24%23.78%35.1%21.14%
FCF per Share4.794.484.313.672.223.253.853.253.002.822.842.482.752.702.742.402.602.581.511.521.251.281.261.291.100.980.950.700.600.490.37
FCF Conversion (FCF/Net Income)1.89x1.97x1.42x1.63x1.43x1.54x1.38x1.32x1.27x1.51x1.29x2.13x1.51x1.43x1.29x1.19x1.46x1.43x1.18x1.27x1.35x1.32x1.32x1.24x1.25x1.31x1.44x1.38x1.39x1.48x1.44x
Interest Paid260M270M302M280M151M194M188M185M194M150M162M131M133M118M77M58M70M98M119M000000000000
Taxes Paid465M0933M937M945M890M845M803M847M1.04B932M1.26B1.01B1.09B1.28B1.01B1.12B1.1B862M000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

FX and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cash Conversion Remains Strong Despite EPS Miss

Operating cash flow exceeded net income in most quarters, with OCF/NI averaging 1.3x over the last ten quarters, indicating high earnings quality despite the recent EPS miss.

The OCF/NI ratio has been consistently above 1.0 except in 2025Q1 (0.87) and 2025Q4 (negative due to a net loss), suggesting that accruals are not inflating earnings. The 2026Q2 ratio of 1.44 indicates robust cash generation relative to reported income, which may reassure investors that the EPS shortfall is not a cash flow problem. However, the negative net income in 2025Q4, driven by a one-time charge, temporarily distorted the ratio, but the subsequent recovery to 1.72 in 2025Q3 and 1.44 in 2026Q2 underscores the underlying cash-generative nature of the business.

Free Cash Flow Momentum Holds Steady

Free cash flow margins have remained resilient, averaging 17.5% over the last four quarters, with 2026Q2 FCF of $867M representing a 16.2% margin, despite revenue growth decelerating to 1.4% TTM.

FCF has been consistently positive and substantial, with the latest quarter's FCF margin of 16.2% slightly below the 2025Q3 peak of 21.6% but still above the 10-quarter average of 17.0%. The stability in FCF margins, even as revenue growth slows, suggests that the company is effectively managing its cash conversion cycle and capital expenditures. However, the deceleration in top-line growth, as noted in the income statement analysis, may eventually pressure FCF if pricing power weakens further, warranting close monitoring of future quarters.

Capital Intensity Remains Low and Disciplined

Capital expenditures have averaged 2.7% of revenue over the last ten quarters, with 2026Q2 CapEx of $128M representing 2.4% of revenue, indicating a low capital intensity business model.

The CapEx/Revenue ratio has been remarkably stable, ranging from 2.1% to 3.7%, with no significant spikes that would suggest a major expansion phase. This low capital intensity supports the company's ability to generate high FCF margins and return substantial cash to shareholders. The modest increase in CapEx in 2024Q4 (3.7%) and 2025Q4 (3.4%) may reflect investments in pet food capacity, but the overall trend suggests maintenance-level spending rather than aggressive growth capex, which aligns with the mature nature of the household products industry.

Working Capital Swings Reflect Seasonal Patterns

Working capital changes have been volatile, with positive contributions in Q4 and Q3 quarters (e.g., $447M in 2025Q4) and negative in Q1 quarters (e.g., -$277M in 2026Q1), indicating seasonal inventory and receivable dynamics.

The working capital changes show a clear seasonal pattern: Q1 typically sees a cash outflow as the company builds inventory and extends receivables, while Q4 sees a large inflow as collections accelerate and inventory is drawn down. This pattern is consistent with a consumer staples company that experiences higher sales in the second half of the year. The 2026Q2 working capital change of $12M is minimal, suggesting that the company is efficiently managing its working capital in the current quarter, but the negative swings in Q1 quarters highlight the need for adequate liquidity to fund seasonal needs.

Shareholder Returns Outpace Cash Generation

Dividends and buybacks totaled $753M in 2026Q2, exceeding FCF of $867M, indicating a payout ratio of 87%, which is sustainable but leaves limited room for other capital allocation.

The company has consistently returned a significant portion of its cash flow to shareholders through dividends and buybacks, with the combined payout ratio averaging over 90% in the last ten quarters. In 2026Q2, dividends of $462M and buybacks of $291M totaled $753M, slightly below FCF of $867M, but in some quarters (e.g., 2024Q1), the payout exceeded FCF, indicating that the company may occasionally dip into cash reserves to maintain its shareholder return program. This aggressive capital deployment underscores management's commitment to returning cash, but it also limits flexibility for large acquisitions or debt reduction, which is a consideration given the recent EPS miss and potential need for investment in growth areas.

Cumulative Cash Generation Exceeds Reported Earnings

Over the last ten quarters, cumulative operating cash flow of $10.2B exceeded cumulative net income of $7.4B by 38%, indicating conservative accrual accounting and high cash conversion.

The cumulative gap between operating cash flow and net income is substantial, with OCF totaling $10.2B versus net income of $7.4B. This divergence suggests that the company's earnings are backed by strong cash generation, and that non-cash charges like depreciation and amortization (averaging $155M per quarter) are significant, but not excessive. The positive working capital contributions in several quarters also boosted OCF, but the overall trend indicates that reported earnings are of high quality. This cumulative cash surplus provides a cushion for the company to maintain its dividend and buyback programs even if earnings face temporary pressure from FX or margin compression.

What Could Invalidate the Base Case

Despite strong cash conversion, the recent EPS miss and decelerating revenue growth may signal that cash flow strength is not immune to margin compression, warranting scrutiny of future quarters.

The cash flow statement obscures potential risks such as the sustainability of working capital benefits, which have contributed to OCF in some quarters. The 2025Q4 net loss, driven by a one-time charge, highlights that reported earnings can be volatile, and the OCF/NI ratio in that quarter was negative, indicating that cash flow can also be affected by such charges. Additionally, the high payout ratio suggests that if FCF declines due to margin compression or increased capex, the company may need to reduce buybacks or take on debt to maintain dividends. Investors should monitor whether the recent EPS miss is a one-off or a precursor to broader cash flow deterioration, especially given the FX headwinds and slowing top-line growth.

CL — Frequently Asked Questions

Quick answers to the most common questions about buying CL stock.

How much cash does Colgate-Palmolive Company (CL) generate from operations?

Colgate-Palmolive Company (CL) generated $4.20B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Colgate-Palmolive Company's free cash flow?

Colgate-Palmolive Company (CL) generated $3.63B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Colgate-Palmolive Company's capital expenditure (CapEx)?

Colgate-Palmolive Company (CL) spent $564.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Colgate-Palmolive Company distribute cash to shareholders?

In 2025, Colgate-Palmolive Company (CL) returned $1.82B to shareholders via cash dividends and spent $1.21B on share repurchases. This shows the company's commitment to returning capital to its equity investors.